SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-018292
Filing Date
2018-06-27
Accepted
2018-06-27 16:00:53
Documents
2
Period of Report
2018-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 EX-24 DOCUMENT attachment1.htm EX-24 3084
  Complete submission text file 0000899243-18-018292.txt   6138
Mailing Address
Business Address
ANDO GORAN (Reporting) CIK: 0001110748 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 18921800

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10